Yayın:
A new series of thiosemicarbazone‐based anti‐inflammatory agents exerting their action through cyclooxygenase inhibition

dc.contributor.authorALTINTOP, MEHLİKA DİLEK
dc.contributor.authorSEVER, BELGİN
dc.contributor.authorÇiftçi, Gülşen Akalın
dc.contributor.authorÖZDEMİR, AHMET
dc.contributor.authorÖzkan Alataş
dc.contributor.authorAhmet Özdemır
dc.contributor.orcid0000-0002-8159-663X
dc.contributor.orcid0000-0003-4847-9711
dc.contributor.orcid0000-0001-5098-8967
dc.contributor.orcid0000-0001-8328-4157
dc.contributor.orcid0000-0003-0280-5550
dc.date.accessioned2025-11-13T10:55:19Z
dc.date.issued2022-05-23
dc.identifier.doihttps://doi.org/10.1002/ardp.202200136
dc.identifier.endpagee2200136
dc.identifier.issn0365-6233
dc.identifier.issue9
dc.identifier.openalexW4281398244
dc.identifier.startpagee2200136
dc.identifier.urihttps://hdl.handle.net/11421/5667
dc.identifier.urihttps://doi.org/10.1002/ardp.202200136
dc.identifier.volume355
dc.language.isoen
dc.relation.ispartofArchiv der Pharmazie
dc.rightsrestrictedAccess
dc.subjectChemistry
dc.subjectPharmacology
dc.subjectAntioxidant
dc.subjectIn vivo
dc.subjectNitric oxide
dc.subjectMalondialdehyde
dc.subjectDocking (animal)
dc.subjectBiochemistry
dc.subjectMyeloperoxidase
dc.subjectEnzyme
dc.subjectProdrug
dc.subjectAnti-inflammatory
dc.subjectCyclooxygenase
dc.subjectIn vitro
dc.subjectLipopolysaccharide
dc.subjectStereochemistry
dc.subjectInflammation
dc.subjectMedicine
dc.subject.sdg6
dc.titleA new series of thiosemicarbazone‐based anti‐inflammatory agents exerting their action through cyclooxygenase inhibition
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5048968214
local.authorid.openalexA5040352588
local.authorid.openalexA5045943806
local.authorid.openalexA5100651829

Dosyalar

Koleksiyonlar